Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 3689-50-7
2. Dysedon
3. Doxergan
4. Imakol
5. Dosegran
6. Oxymemazine
7. Alimemazine S,s-dioxide
8. Oplex
9. Rp 6847
10. Exe-top
11. Trimeprazine 5,5-dioxide
12. (+)-oxomemazine
13. (-)-oxomemazine
14. Oxomemazine, (+)-
15. Oxomemazine, (-)-
16. 10-(3-(dimethylamino)-2-methylpropyl)-10h-phenothiazine 5,5-dioxide
17. 10-(3-(dimethylamino)-2-methylpropyl)phenothiazine 5,5-dioxide
18. 3-(5,5-dioxophenothiazin-10-yl)-n,n,2-trimethylpropan-1-amine
19. Rp-6847
20. Q824sgh3rn
21. 6847 R.p.
22. 10-(3-(dimethylamino)-2-methylpropyl)phenothiazine-5,5-dioxide
23. 305mb38v1c
24. 5gp9538p4s
25. 10h-phenothiazine-10-propanamine, N,n,.beta.-trimethyl-, 5,5-dioxide
26. Oxomemazine (inn)
27. 6487-rp
28. 6847-rp
29. Oxomemazine [inn]
30. Phenothiazine, 10-(3-(dimethylamino)-2-methylpropyl)-, 5,5-dioxide
31. Oxomemazin
32. Oxomemazina
33. Oxomemazinum
34. Oxomemazine [inn:dcf]
35. Phenothiazine, 10-[3-(dimethylamino)-2-methylpropyl]-, 5,5-dioxide
36. Oxomemazinum [inn-latin]
37. Oxomemazina [inn-spanish]
38. Einecs 222-996-8
39. 174508-13-5
40. 174508-14-6
41. Ncgc00182075-03
42. Brn 0289178
43. Unii-305mb38v1c
44. Doxergan (tn)
45. Oxomemazine [mi]
46. Dioxo-9,9-(dimethylamino-3-methyl-2-propyl)-10-phenothiazine [french]
47. Unii-q824sgh3rn
48. Oxomemazine [mart.]
49. (+/-)-oxomemazine
50. Oxomemazine [who-dd]
51. 4-27-00-01270 (beilstein Handbook Reference)
52. Mls006009989
53. Schembl423634
54. Unii-5gp9538p4s
55. Chembl2104734
56. Dtxsid5023405
57. Chebi:135408
58. Dioxo-9,9-(dimethylamino-3-methyl-2-propyl)-10-phenothiazine
59. Oxomemazine 1.0 Mg/ml In Methanol
60. Mfcd00868197
61. Akos015962134
62. 6487 Rp
63. 6847 Rp
64. Db13820
65. Ncgc00182075-02
66. Ac-15943
67. Smr004701064
68. Hy-136587
69. Cs-0131898
70. Ft-0698324
71. D07401
72. F20164
73. Sr-01000883964
74. Q3359071
75. Sr-01000883964-1
76. 10h-phenothiazine-10-propanamine, N,n,beta-trimethyl-, 5,5-dioxide, (+)-
77. 10h-phenothiazine-10-propanamine, N,n,beta-trimethyl-, 5,5-dioxide, (-)-
78. 3-(5,5-dioxido-10h-phenothiazin-10-yl)-n,n,2-trimethyl-1-propanamine #
79. 3-(5,5-dioxido-10h-phenothiazin-10-yl)-n,n,2-trimethylpropan-1-amine
80. 10h-phenothiazine-10-propanamine, N,n,.beta.-trimethyl-, 5,5-dioxide, (+)-
81. 10h-phenothiazine-10-propanamine, N,n,.beta.-trimethyl-, 5,5-dioxide, (-)-
| Molecular Weight | 330.4 g/mol |
|---|---|
| Molecular Formula | C18H22N2O2S |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 4 |
| Exact Mass | 330.14019912 g/mol |
| Monoisotopic Mass | 330.14019912 g/mol |
| Topological Polar Surface Area | 49 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 470 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
R - Respiratory system
R06 - Antihistamines for systemic use
R06A - Antihistamines for systemic use
R06AD - Phenothiazine derivatives
R06AD08 - Oxomemazine
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Market Place
ABOUT THIS PAGE
67
PharmaCompass offers a list of Oxomemazine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Oxomemazine manufacturer or Oxomemazine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oxomemazine manufacturer or Oxomemazine supplier.
PharmaCompass also assists you with knowing the Oxomemazine API Price utilized in the formulation of products. Oxomemazine API Price is not always fixed or binding as the Oxomemazine Price is obtained through a variety of data sources. The Oxomemazine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Doxergan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Doxergan, including repackagers and relabelers. The FDA regulates Doxergan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Doxergan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Doxergan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Doxergan supplier is an individual or a company that provides Doxergan active pharmaceutical ingredient (API) or Doxergan finished formulations upon request. The Doxergan suppliers may include Doxergan API manufacturers, exporters, distributors and traders.
click here to find a list of Doxergan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Doxergan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Doxergan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Doxergan GMP manufacturer or Doxergan GMP API supplier for your needs.
A Doxergan CoA (Certificate of Analysis) is a formal document that attests to Doxergan's compliance with Doxergan specifications and serves as a tool for batch-level quality control.
Doxergan CoA mostly includes findings from lab analyses of a specific batch. For each Doxergan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Doxergan may be tested according to a variety of international standards, such as European Pharmacopoeia (Doxergan EP), Doxergan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Doxergan USP).
